Nucleic acid-based vaccines targeting respiratory syncytial virus: Delivering the goods

Nucleic acid-based vaccines targeting respiratory syncytial virus: Delivering the goods

Respiratory syncytial virus (RSV) is a massive medical burden on a global scale. Infants, children and the elderly represent the vulnerable populations. Currently there is no approved vaccine to protect against the disease. Vaccine development has been hindered by several factors including vaccine e...

Full description

Bibliographic Details
Main Authors: Trevor R. F. Smith, Katherine Schultheis, Kate E. Broderick
Format: Article
Language:English
Published: Taylor & Francis Group 2017-11-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
respiratory syncytial virus
vaccine delivery
dna/rna vaccine
Online Access:http://dx.doi.org/10.1080/21645515.2017.1363134

Similar Items

Similar Items